Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1000
Trial Sponsor
Clinical Trial Start Date
April 9, 2021
0Primary Completion Date
June 9, 2023
0Study Completion Date
August 9, 2023
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Immunity Against the COVID-19 Vaccine in Healthcare Workers of Buenos Aires, Argentine0
Last Updated
September 22, 2023
0Study summary
Vaccination against coronavirus disease 19 (COVID-19) is an essential primary prevention tool to limit the health and economic effects of the pandemic. Objectives: To determine the variation in the levels of Immunoglobulin G (IgG) antibodies in health workers who received a COVID-19 vaccine.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
